Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Anne Lennard

Newcastle AuthorsTitleYearFull text
Dr Anne Lennard
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial2018
Dr Michal Sieniawski
Dr Katrina Wood
Dr Anne Lennard
High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study2018
Joseph O'Donoghue
Dr Anne Lennard
Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent2017
Dr Anne Lennard
Outcomes with rituximab monotherapy versus r-chop in post-transplant lymphoproliferative disease arising after solid organ transplant: a United Kingdom multicentre study2016
Dr Michal Sieniawski
Dr Anne Lennard
A New and Validated Clinical Prognostic Model (EPI) for Enteropathy-Associated T-cell Lymphoma2015
Dr Anne Lennard
Dr Viney Wadehra
Anaplastic large cell lymphoma in a reconstructed breast using a silicone implant: A UK case report2014
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Anne Lennard
Impact of p53 positive p21 negative phenotype on outcome in CHOP-R treated DLBCL patients2014
Dr Michal Sieniawski
Dr Anne Lennard
Enteropathy-Associated T-Cell Lymphoma: Epidemiology, Clinical Features, and Current Treatment Strategies2011
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation2010
Professor Stephen Proctor
Dr Anne Lennard
Professor Graham Jackson
Dr Jennifer Wilkinson
Dr Michal Sieniawski
et al.
The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control2010
1234567